Scientists have discovered two bacteria with great antibiotic potential in a river in Chile.
The breakthrough comes as the search for new bacteria to develop antibiotics is one of humankind’s greatest health challenges as bacterial infections are increasingly resistant to conventional medical treatments.
The two bacteria were found by researchers at the Institute of Biomedical Sciences of the Faculty of Medicine of the University of Chile (ICBM), according to a statement Zenger News obtained Wednesday from the University of Chile.
This reportedly occurred while the researchers were testing a cholera-causing bacteria’s ability to survive in water in the Mapocho River, which flows from the Andes mountains and cuts through the capital city of Santiago in Chile.
The bacteria are categorized as Pseudomona koreinsis I1 and Desemzia inserta I2 respectively and act as inhibitors of pathogens, according to the statement.
This means that they contain promising antibiotic potential and could be used to combat antibiotic resistance.
Further investigation into the discovery, in a project financed by The National Fund for Scientific and Technological Development (FONDECYT) in Chile, will allow the team to study the antimicrobial molecules produced by the microorganisms.
This could lead to new formulas that could help address the global antibiotic resistance crisis. An estimated 10 million people will die annually starting in the year 2050 due to multi-resistant strains, according to the World Health Organization (WHO).
The WHO added: “Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.”
Victor Garcia, an academic from ICBM’s Microbiology and Mycology program who led the team, stated that searches for the bacteria have taken place in ecological niches where unique bacteria is expected to be found.
He added: “Since these are little-explored environments, one hopes to find new molecules because one of the big problems today is that, when inhibitory bacteria are found, the antimicrobials they produce have already been described before.
“(It is) very likely we will solve the problem of finding already known molecules.
“Our project has to do with the discovery and characterization of these molecules, in the context of the critical problem for humanity that is the resistance of antibiotics to bacteria.”
The incorporation of exotic DNA from wild relatives into wheat results in a remarkable yield increase of up to 50%, even in hot weather, surpassing elite lines without these genes. Amid a year of [...]
Australia has become the first country to recognise psychedelics as medicines, after the Therapeutic Goods Administration took researchers by surprise and approved the psychedelic substances in magic mushrooms and MDMA for use by people [...]
In a new study, scientists with the University of Florida have found that a combination of silver nanoparticles and antibiotics is effective against antibiotic-resistant bacteria. The researchers hope to turn this discovery into viable [...]
Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with [...]
According to a new study by researchers at Penn Medicine, ketamine, which is well-known as an anesthetic and is becoming increasingly popular as an antidepressant, dramatically reorganizes activity in the brain, almost as if [...]
A new immunotherapy releases cancer-killing cytokines only within the tumor. Researchers at the University of California San Francisco (UCSF) have developed a new T cell-based immunotherapy that selectively targets cancer cells, producing a powerful anti-cancer cytokine [...]
An AI was tasked with creating proteins with anti-microbial properties. Researchers then created a subset of the proteins and found some did the job. An AI has designed anti-microbial proteins that were then tested [...]
Treating cancer with combinations of drugs can be more effective than using a single drug. However, figuring out the optimal combination of drugs, and making sure that all of the drugs reach the right [...]
By one unique metric, we could approach technological singularity by the end of this decade, if not sooner. A translation company developed a metric, Time to Edit (TTE), to calculate the time it takes for professional [...]
Phase transition in early universe changes strength of interaction between dark and normal matter. Dark matter remains one of the greatest mysteries of modern physics. It is clear that it must exist, because without [...]
Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of [...]
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The [...]
Using a mouse model, Japanese researchers unleash the likely mechanism of action of Actinidia arguta (sarunashi) juice on lung cancer development. Lung cancer is a leading cause of death in Japan and across the [...]
When used as wearable medical devices, stretchy, flexible gas sensors can identify health conditions or issues by detecting oxygen or carbon dioxide levels in the breath or sweat. They also are useful for monitoring [...]
Novel drugs, such as vaccines against covid-19, among others, are based on drug transport using nanoparticles. Whether this drug transport is negatively influenced by an accumulation of blood proteins on the nanoparticle’s surface was [...]
The costly lesson from COVID: why elimination should be the default global strategy for future pandemics
Imagine it is 2030. Doctors in a regional hospital in country X note an expanding cluster of individuals with severe respiratory disease. Rapid whole-genome sequencing identifies the disease-causing agent as a novel coronavirus. Epidemiological [...]